Track record · closed signal

UiPath, Inc. (PATH) — closed signal from October 26, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 24, 2026.

Predicted vs. what happened

PATH price · publication thesis → realized outcomesplit-adjusted
$16.48 Published $22.25 Target $14.80 Window close $19.84 Peak
$16.20 – $16.60Entry zone — fair-value band
$16.48Published — price the day we called it
$22.25Target — the price the thesis aimed for
$19.84Peak — highest point inside the window, not a realized return
$14.80Window close — end-of-window price, context only

What happened

Partial

Reached 58% of the predicted growth at its peak, without hitting the target.

Peak price
$19.84
peak on December 8, 2025 — not a realized return
Peak gain
+20.4%
peak, from the publication price
Window close
$14.80
end-of-window price, context only
Days to target
—
Window
October 26, 2025 – January 24, 2026

The thesis — published October 26, 2025

Predicted growth
+35%
over the measurement window
Target price
$22.25
the price the thesis aimed for
Entry zone
$16.20 – $16.60
the fair-value band we waited for
Price at publication
$16.48
published October 26, 2025
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

UiPath looks ready for a rebound after a tough slide. The price seems washed out, the recent average price is turning up, and news includes a UBS upgrade. The company grew sales 14 percent compared to last year and its recurring subscriptions rose 11 percent. Start near $16.20-$16.60 and consider adding if strength builds above $17.20. Over the next 0-3 months, AI automation wins could help, but profits and rivals limit confidence.

Primary drivers

  • Price looks beaten down, and the recent average price trend is improving
  • UBS raised its view, and sales and recurring revenue are moving up
  • More companies want AI tools to automate work, save time, and cut costs
  • Profit is still developing, and strong rivals could slow the company

How it played out

PATH: thesis partly played out but target was missed

Lyra published PATH at $16.48 on 2025-10-26 with a short-term thesis for 35% growth. The thesis pointed to a washed-out price, an improving recent average price trend, a UBS upgrade, 14% sales growth from last year, 11% recurring subscription growth, demand for artificial intelligence automation tools, and risks from profits and rivals.

Inside the 2025-10-26 to 2026-01-24 window, PATH rose to $19.84 on 2025-12-08, a 20.4% peak gain. It stayed below the $22.25 target and never reached it. By the end of the window, it was $14.80. The verdict was partial: the rebound happened, but the target did not.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All PATH signals